for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-New Ntm Treatment Guidelines Recommend Insmed's Arikayce For Treatment Of Patients With Refractory Mac Lung Disease

July 7 (Reuters) - Insmed Inc:

* NEW NTM TREATMENT GUIDELINES RECOMMEND INSMED’S ARIKAYCE® (AMIKACIN LIPOSOME INHALATION SUSPENSION) FOR TREATMENT OF PATIENTS WITH REFRACTORY MAC LUNG DISEASE Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up